Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Atea to study AT-527 as monotherapy and in combination for Covid-19

Pharmaceutical-TechnologyDecember 16, 2021

Tag: Atea , AT-527 , COVID-19

PharmaSources Customer Service